IMpower133: Updated overall survival (OS) analysis of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC)

Martin Reck, Stephen V. Liu, Aaron Scott Mansfield et al. · Annals of Oncology · 2019

Cited by 68 works. doi:10.1093/annonc/mdz264 Open-access PDF

Authors